Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0000899243-19-000956

President sold 100,000 shares at an average $35.02 ($3,502,385)

From the SEC's structured data for this filing

Trades in this filing

Novak Rodger · President

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2019-01-08 Sale : show line 1 in the form −17,310 $35.09 $607,408 1,130,697 D
2019-01-09 Sale : show line 2 in the form −82,690 $35.01 $2,894,977 1,048,007 D
Open-market sales · 100,000 sh · avg $35.02 · $3,502,385
Loading xslF345X03/doc4.xml…